NCT00571155View on ClinicalTrials.gov

Trial of Levetiracetam in Patients With Primary Brain Tumors and Symptomatic Seizures Who Undergo Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

August 31, 2009

Study Completion Date

August 31, 2009

Conditions
Primary Brain TumorEpilepsy
Interventions
DRUG

levetiracetam

oral and intravenous dosing 2000-3000 mg per day

Trial Locations (1)

72076

University Hospital Tuebingen, Department of General Neurology, Tübingen

All Listed Sponsors
lead

University Hospital Tuebingen

OTHER

NCT00571155 - Trial of Levetiracetam in Patients With Primary Brain Tumors and Symptomatic Seizures Who Undergo Surgery | Biotech Hunter | Biotech Hunter